Serum pro-gastrin-releasing peptide (31-98) in benign prostatic hyperplasia and prostatic carcinoma

By Nagakawa O.   Furuya Y.   Fujiuchi Y.   Fuse H.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 527-530

Elsevier

Access to resources Recommend Favorite

Time-Dependent Changes of Serum Gastrin and Gastrin Receptors in the Rat Oxyntic Mucosa after Proximal Gastric Vagotomy

By Reina A.J.   Lopez-Cantarero M.   Gallardo A.   Fuentes O.   Gaitan D.   Garcia A.   Gonzalez C.   Acuna-Castroviejo D.  

Journal of Surgical Research, Vol. 67, Iss. 2, 1997-02 ,pp. : 186-192

Academic Press

Access to resources Recommend Favorite

Treatment of men with minimally symptomatic benign prostatic hyperplasia-PRO: the argument in favor

By Marks L.S.  

Urology, Vol. 62, Iss. 5, 2003-11 ,pp. : 781-783

Elsevier

Access to resources Recommend Favorite

Serum Interleukin-11 in Patients with Benign Prostatic Hyperplasia and Prostate Cancer

By Furuya Yuzo   Nishio Remon   Junicho Akira   Nagakawa Osamu   Fuse Hideki  

International Urology and Nephrology, Vol. 37, Iss. 1, 2005-03 ,pp. : 69-71

Springer Publishing Company

Access to resources Recommend Favorite

Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer - a marker of androgen-independent (AI) growth in prostatic carcinoma (PC).(abstract)

By Veltri R.W.   Miller M.C.   Zhao G.   Ng A.   Marley G.M.   Wright G.L.   Vessella R.L.   Ralph D.  

Urology, Vol. 53, Iss. 1, 1999-01 ,pp. : 139-147

Elsevier

Access to resources Recommend Favorite